EP3673890A1 - Medizinischer infusionsbeutel - Google Patents

Medizinischer infusionsbeutel Download PDF

Info

Publication number
EP3673890A1
EP3673890A1 EP18849069.2A EP18849069A EP3673890A1 EP 3673890 A1 EP3673890 A1 EP 3673890A1 EP 18849069 A EP18849069 A EP 18849069A EP 3673890 A1 EP3673890 A1 EP 3673890A1
Authority
EP
European Patent Office
Prior art keywords
medical solution
solution bag
chemical
vent hole
accommodated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18849069.2A
Other languages
English (en)
French (fr)
Other versions
EP3673890A4 (de
Inventor
Kwang Soo Park
Ki Pyo Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HK Inno N Corp
Original Assignee
CJ Healthcare Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CJ Healthcare Corp filed Critical CJ Healthcare Corp
Publication of EP3673890A1 publication Critical patent/EP3673890A1/de
Publication of EP3673890A4 publication Critical patent/EP3673890A4/de
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents

Definitions

  • the present invention relates to a medical solution bag, and more particularly to a medical solution bag that includes an auxiliary chamber, in which a chemical is accommodated, in addition to a main chamber, in which a solution is accommodated, such that the chemical accommodated in the auxiliary chamber is easily additionally injected when the solution accommodated in the main chamber is injected as the chemical is simply mixed with the solution.
  • a medical solution such as a physiological sodium chloride solution or glucose is kept in a solution container having a predetermined shape.
  • the solution container is generally formed to have a bottle shape.
  • the solution container having a bottle shape that is, the solution bottle is formed of glass, and because it is easily broken by an impact due to the characteristics of the material, it is difficult to treat it.
  • the solution bag is formed of a flexible material such as a synthetic resin film, it is easy to treat it because it can be hardly damaged due to the characteristics of the material.
  • an amino acid solution and a glucose solution are mixed and kept they are browned, if a fatty oil and an electrolyte solution are mixed and kept, the fatty components are condensed, and if a phosphoric acid-containing liquid and a calcium-containing liquid are mixed and kept, calcium phosphate is precipitated.
  • a conventional medical solution bag A' having multiple chambers has a plurality of main chambers 100' that are separated and partitioned by sealing parts 11' in a body 10', the different kinds of solutions are prevented from being mixed as the solutions are accommodated in the main chambers 100', respectively.
  • sealing parts 11' that separate and partition the plurality of main chambers 100' are simply separated by applying an appropriate pressure, the sealing parts 11' are separated shortly before the solutions are injected so that the mixed solutions can be injected as the different kinds of solutions accommodated in the main chambers 100', respectively, are mixed.
  • the medical solution bag having multiple chambers can prevent the solutions from being mixed when being kept, but it is troublesome to additionally inject a chemical such as a vitamin agent in the solution injecting process.
  • the medical solution bag having multiple chambers cannot additionally accommodate a chemical in addition to the solutions accommodated in the main chambers, and when a chemical is to be additionally injected in addition to the solutions accommodated in the main chambers, preparation of an additional member such as preparation of a separate injection needle is necessary, which is troublesome.
  • the present invention has been made in an effort to solve the above-mentioned problems, and provides a medical solution bag that can solve a problem of having a troublesomeness of providing an injection needle because the injection needle has to be used when a chemical is additionally injected because a chemical except for solutions accommodated in main chambers cannot be used when a conventional medical solution bag having multiple chambers are used.
  • a medical solution bag including: a main chamber in which a solution is accommodated in a bag-shaped body thereof; a main port configured to interrupt discharge of the solution from the interior to the outside of the main chamber; and an auxiliary chamber including a fixing member fixedly installed at one end of the body and communicating with the main chamber through a vent hole passing through a central portion thereof, and a storage member installed to be inserted into the vent hole of the fixing member and in which a chemical, the kind of which is different from the solution accommodated in the main chamber, is separately accommodated in an interior space thereof.
  • the main chamber may be separated and partitioned by a sealing part formed to cross the interior of the body.
  • the sealing part may be separated through pressing.
  • the main port may be coupled to the separated/partitioned areas of the main chamber.
  • the fixing member may be coupled to the body through thermal fusion or high-frequency fusion.
  • the vent hole may include: an annular step formed at a circumference of an outer surface of an upper end of the vent hole; a step formed at a circumference of an inner surface of an intermediate part between the upper end and a lower end of the vent hole to protrude inwards; and a stopping step formed at a circumference of an inner surface of the lower end of the vent hole.
  • the storage member may include: a cover configured to interrupt opening of an upper end of the interior space; and a cap configured to interrupt opening of a lower end of the interior space.
  • the cap includes a breaking part that may be broken through pressing.
  • the thickness of the breaking part may be smaller than those of the other parts.
  • the storage member further may include: a stopping piece formed at a circumference of the intermediate part between the upper end and the lower end to be dually folded downwards and inwards; and a step formed to protrude outwards.
  • the auxiliary chamber may further include an O-ring configured to maintain a sealing state between the fixing member and the storage member.
  • An outer surface of the auxiliary chamber may be surrounded by a light-shielding film.
  • the medical solution bag according to the present invention includes an auxiliary chamber, in which a chemical is separately accommodated, in addition to main chambers, in which a solution is accommodated, and because the solutions and the chemical are simply mixed by introducing the chemical in the auxiliary chamber into the main chamber, the chemical can be easily injected in addition to the solutions.
  • a medical solution bag A includes a main chamber 100, a main port 200, and an auxiliary chamber 300.
  • a solution (not denoted by a reference numeral) is accommodated in a bag-shaped body 10.
  • the main chamber 100 may be separated and partitioned by a sealing part 11 formed to cross the interior of the body 10.
  • the sealing part 11 may be separated through pressing.
  • the mixed solution may be injected.
  • a plurality of sealing parts 11 may be formed, and because the number of the separated/partitioned areas of the main chamber 100 increases if the plurality of sealing parts 11 are formed, more various kinds of solutions may be accommodated through the main chamber 100.
  • the main port 200 interrupts discharge of the solution from the interior to the outside of the main chamber 100.
  • the main port 200 may be coupled to the separated/partitioned areas of the main chamber 100.
  • the solutions accommodated in the separated/partitioned areas of the main chamber 100 may be individually injected through the main port 200.
  • a main port 100 having any scheme that may interrupt discharge of the solutions accommodated in the main chamber 100 is sufficient, and an example thereof may be an injection port into which an injection needle is inserted or an infusion port into which a spike is inserted.
  • the auxiliary chamber 300 includes a fixing member 310 fixedly installed at one end of the body 10 and communicating with the main chamber 100 through a vent hole 311 passing through a central portion thereof, and a storage member 320 installed to be inserted into the vent hole 311 of the fixing member 310 and in which a chemical, the kind of which is different from the solution accommodated in the main chamber 100, is separately accommodated in an interior space thereof.
  • the fixing member 310 is coupled to the body 10 through thermal fusion or high-frequency fusion, leakage of the solution and the chemical through a coupling part of the fixing member 310 is prevented due to the characteristics of the coupling scheme.
  • vent hole 311 of the fixing member 310 includes an annular step 311a formed at a circumference of an outer surface of an upper end thereof.
  • vent hole 311 of the fixing member 310 includes a step 311b formed at a circumference of an inner surface of an intermediate portion between an upper end and a lower end thereof to protrude inwards.
  • a step 324 of the storage member 320 which will be described below, is stopped by the step 311b of the fixing member 310, insertion of the storage member 320 into the vent hole 311 is restricted.
  • vent hole 311 of the fixing member 310 includes a stopping step 311c formed at a circumference of an inner surface of a lower end thereof.
  • a cap 321 of the storage member 320 which will be described below, drops after the cap 321 is broken and is stopped by the stopping step 311c, separation of the cap 321 from the vent hole 311 is prevented.
  • the storage member 320 includes a cover 322 configured to interrupt opening of an upper end of the interior space, and a cap 321 configured to interrupt opening of a lower end of the interior space.
  • the cap 321 includes a breaking part 321a that is broken through pressing.
  • the chemical in the storage member 320 is simply introduced into any one of the main chambers 100 in the body 10 via the vent hole 311 of the fixing member 310.
  • the thickness of the breaking part 321a is relatively small as compared with the thicknesses of the other parts, it is easily broken through pressing.
  • the chemical in the storage member 320 flows downwards along a convexo-concave portion when the cap 321 is broken along the breaking part 321a as the cap 321 has the convexo-concave portion (not denoted by a reference numeral) at a circumference of an upper end thereof, the chemical is smoothly discharged even in a state in which the broken cap 321 is stopped by the stopping step 311c formed at a lower end of the vent hole 311 of the fixing member 310.
  • the storage member 320 further includes a stopping piece 323 at a circumference of an outer surface of the intermediate part between the upper end and the lower end to be dually folded downwards and inwards
  • the stopping piece 323, as described above, is stopped by the annular step 311a formed at a circumference of an outer surface of an upper end of the vent hole 311 of the fixing member 310.
  • the storage member 320 further includes a step 324 formed at a circumference of an outer surface of the intermediate part between the upper end and the lower end to protrude outwards.
  • the step 324 is stopped by the step 311b formed at a circumference of an inner surface of the intermediate part between the upper end and the lower end of the vent hole 311 of the fixing member 310 to protrude inwards.
  • the auxiliary chamber 300 further includes an O-ring 330 configured to maintain a sealing state between the fixing member 310 and the storage member 320.
  • the O-ring 330 may be seated between the step 311b formed in the vent-hole 311 of the fixing member 310 and the step 324 formed in the storage member 320.
  • an outer surface of the auxiliary chamber 300 may be surrounded by the light-shielding film 340.
  • the light-shielding film 340 interrupts exposure of the chemical, which is accommodated in the storage member 320, to light, modification of the chemical by the exposure to light can be prevented.
  • any typical material that may interrupt exposure of the chemical to light is sufficient for the light-shielding film 340, and an example thereof may be an aluminum deposited film.
  • the main port 200 extends from the interior to the outside of the main chamber 100, and because an injection needle or a spike is inserted into one end of the outside of the main port 200, the solution accommodated in the main chamber 100 may be injected through the main port 200.
  • the present invention includes the auxiliary chamber 300 in which the chemical is separately accommodated in addition to the main chambers 100 in which the solutions are accommodated, respectively, and because the chemical in the auxiliary chamber 300 is introduced into the main chamber 100, the chemical is easily additionally injected.
  • the storage member 320 in which the chemical is accommodated, is inserted into the inside of the vent hole 311 formed to pass through a central portion of the fixing member 310 communicating with any one of the main chambers 100 of the body 10, and as illustrated in FIG. 2 , because the solutions and the chemical are mixed as the chemical in the storage member 320 is introduced into the interior of the body 10, the chemical may be additionally injected.
  • the cap 321 that interrupts opening of the lower end of the interior space of the storage member 320 includes the breaking part 321a having a thickness that is smaller than the thicknesses of the other parts, and as illustrated in FIG. 5 , because the chemical in the storage member 320 is introduced into the body 10 via the vent hole 311 of the fixing member 310 as the breaking part 321a is broken, the solutions and the chemical may be simply mixed, and accordingly, the chemical may be smoothly additionally injected.
  • the chemical may be leaked through a space between the fixing member 310 and the storage member 320.
  • the auxiliary chamber 300 includes the O-ring 330, and because the sealing state between the fixing member 310 and the storage member 320 is maintained by the O-ring 330, leakage of the chemical through a space between the fixing member 310 and the storage member 320 is prevented.
  • the cap 321 broken in the storage member 320 is separated from the fixing member 310, the additional injection of the chemical may be interfered.
  • the vent hole 311 of the fixing member 310 includes the stepping step 311c formed at a circumference of the inner surface of the lower end thereof, and because the separation of the cap 321 from the fixing member 310 is prevented as the cap 321 broken in the storage member 320 is stopped by the stopping step 311c, interference with the additional injection of the chemical due to the cap 321 broken in the storage member 320 is prevented.
  • the chemical accommodated in the auxiliary chamber 300 in more detail, in the storage member 320 may be modified by exposure to light.
  • the outer surface of the auxiliary chamber 300 may be surrounded by the light-shielding film 340, and because exposure of the chemical accommodated in the storage member 320 to light is interrupted, modification of the chemical due to the exposure to light is prevented.
  • the medical solution bag A includes the auxiliary chamber 300, in which the chemical is separately accommodated, in addition to the main chamber 100, in which the solution is accommodated, and because the solutions and the chemical are simply mixed by introducing the chemical in the auxiliary chamber 300 into the main chamber 100, the chemical can be easily additionally injected when the solution is injected.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Fluid Mechanics (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
EP18849069.2A 2017-08-25 2018-08-24 Medizinischer infusionsbeutel Withdrawn EP3673890A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170107810A KR101964384B1 (ko) 2017-08-25 2017-08-25 의료용 수액백
PCT/KR2018/009799 WO2019039908A1 (ko) 2017-08-25 2018-08-24 의료용 수액백

Publications (2)

Publication Number Publication Date
EP3673890A1 true EP3673890A1 (de) 2020-07-01
EP3673890A4 EP3673890A4 (de) 2021-05-19

Family

ID=65439482

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18849069.2A Withdrawn EP3673890A4 (de) 2017-08-25 2018-08-24 Medizinischer infusionsbeutel

Country Status (4)

Country Link
EP (1) EP3673890A4 (de)
KR (1) KR101964384B1 (de)
CN (1) CN111031994A (de)
WO (1) WO2019039908A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102255967B1 (ko) * 2020-09-03 2021-05-25 주식회사 메디원 수액백 장착용 튜브

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4606734A (en) * 1984-02-22 1986-08-19 Abbott Laboratories Container mixing system with externally mounted drug container
JP2000116749A (ja) * 1998-10-15 2000-04-25 Showa Denko Kk 輸液容器
JP2000167022A (ja) * 1998-12-04 2000-06-20 Showa Denko Kk 複室医療容器
JP2001009006A (ja) * 1999-06-29 2001-01-16 Terumo Corp 複室容器
US7175614B2 (en) * 2002-10-17 2007-02-13 Baxter International Inc. Peelable seal
JP5088604B2 (ja) * 2004-07-09 2012-12-05 味の素株式会社 薬剤収納封止体
JP4472571B2 (ja) * 2004-08-25 2010-06-02 テルモ株式会社 医療用容器用筒状体、医療用容器用薬剤容器、医療用容器用排出ポートおよび医療用容器
US7789852B2 (en) * 2004-11-26 2010-09-07 Hosokawa Yoko Co., Ltd. Medical liquid container and preparation-containing medical liquid container
JP4956015B2 (ja) * 2006-02-21 2012-06-20 テルモ株式会社 輸液用容器
US20100327016A1 (en) * 2007-04-05 2010-12-30 Fredrick Michael Coory Dispenser
DE102007028733A1 (de) * 2007-06-21 2008-12-24 Fresenius Kabi Deutschland Gmbh Behältnis zur Verwendung in der enteralen Ernährung
KR100946349B1 (ko) 2008-03-28 2010-03-08 이영옥 수액백
KR101124328B1 (ko) * 2010-05-10 2012-03-16 (주)메디파마플랜 다중챔버를 갖는 의료용 수액백 키트
JP4844703B1 (ja) * 2010-09-09 2011-12-28 Ｄｉｃプラスチック株式会社 二剤混合容器
KR101221314B1 (ko) * 2010-10-19 2013-01-10 김준배 약액 적하용기
WO2014103411A1 (ja) * 2012-12-28 2014-07-03 味の素株式会社 複室容器
KR20150002026A (ko) * 2013-06-28 2015-01-07 이상운 주사기형 보조챔버를 갖는 수액백 키트
ES2629294T3 (es) * 2014-07-02 2017-08-08 Paolo Gobbi Frattini S.R.L. Envase flexible con una cámara estéril y hermética para la reconstitución y la administración de sustancias medicinales o nutricionales fluidas instilables en el cuerpo de un paciente
KR101611859B1 (ko) * 2015-04-24 2016-04-14 제이더블유케미타운 주식회사 혼합형 다중 챔버 용기

Also Published As

Publication number Publication date
WO2019039908A1 (ko) 2019-02-28
KR101964384B1 (ko) 2019-04-01
CN111031994A (zh) 2020-04-17
EP3673890A4 (de) 2021-05-19
KR20190022058A (ko) 2019-03-06

Similar Documents

Publication Publication Date Title
RU2214216C2 (ru) Устройство соединения между сосудом и емкостью и система, содержащая такое устройство
US6571837B2 (en) Transfer set for vials and medical containers
US4402420A (en) Dual function port cap
KR20040086373A (ko) 의료용 복실 용기
IL160732A (en) Transfer facility
EP3932452B1 (de) Vorgefüllte spritze, verfahren zur herstellung einer vorgefüllten spritze und verfahren zur vergrösserung der oberfläche
JP3342933B2 (ja) 完全取出式容器及び方法
US12390398B2 (en) Connector for a medical container
EP3673890A1 (de) Medizinischer infusionsbeutel
EP3235488B1 (de) Port und arzneimittellösungsbeutel
US11925601B2 (en) Device for temporarily connecting two containers
EP0591156B1 (de) Behälter für einheitsdosis
KR20170107450A (ko) 포트의 제조 방법, 및 약액백의 제조 방법
HK1001552B (en) Unit dose container
AU2016259761B2 (en) Container for a medical liquid
EP3673889A1 (de) Medizinischer infusionsbeutel
JP7428543B2 (ja) カバー部材付きスパウト
KR102650266B1 (ko) 생체조직 보관용 안전용기
US8006851B2 (en) Child-proof capsule with a syringe doser
US20260124113A1 (en) Connector for a medical container
EP4112102A1 (de) Verriegelungsadapter, spritzenanordnung und vorgefüllte spritze
JP2006051085A (ja) 複室容器
CN104781158A (zh) 吸嘴、带吸嘴的包装体、以及该包装体的制造方法
HK1242179B (en) Port production method and medical solution bag production method
HK1242179A1 (en) Port production method and medical solution bag production method

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200228

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HK INNO.N CORPORATION

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210419

RIC1 Information provided on ipc code assigned before grant

Ipc: A61J 1/20 20060101AFI20210413BHEP

Ipc: A61J 1/10 20060101ALI20210413BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230523

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20231003